Truist Financial (TFC)

NYSEFinancialsBanks - RegionalSnapshot 2026-10-15

$47.07+1.07%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Truist Financial’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.0%

+10% or more+5%0%−5%−10% or less

5.00 → 5.00 EPS · FY ending Dec 31, 2027 · 16 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 15 to 16; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Return capital to shareholders via buybacks and dividends	A primary condition in Truist Financial's published investment case. The stated target is Repurchase at least $1.1 billion common shares per quarter.	Intact	Quarterly share repurchases fall below $1 billion	Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Truist consistently returned capital via dividends and share repurchases, with $1.2B repurchased in 2026-Q2 and dividend payout ratio at 42%. Total payout ratios ranged from 87% to 129% in recent quarters, showing consistent capital return. The trajectory matches management's stated commitment. Delivery assessment Oct 15, 2026
Effective execution of growth initiatives under new CEO	The new CEO supports growth initiatives.	Improving	Revenue declines further or growth initiatives show no progress after CEO transition	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Revenue grew from $4.99B in 2025-Q2 to $5.27B in 2026-Q2, and net income increased from $1.18B to $1.55B over the same period. CEO commentary consistently emphasizes disciplined execution and growth in attractive markets, indicating the company is delivering on this priority. Delivery assessment Oct 15, 2026
Revenue growth near consensus	A primary condition in Truist Financial's published investment case. The stated target is >= -6% YoY revenue growth.	Intact	YoY revenue growth falls below -6% in FY26	Revenue growth: -3.04% FY2026-Q2; GAAP. Published target: >= -6% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Jul 31, 2026-3.038674 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 3f96f166-57b7-40a2-9908-ab94424d7e88. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 8 of last 8 quarters. Revenue grew from $4.99B in 2025-Q2 to $5.27B in 2026-Q2, and net income increased from $1.18B to $1.55B over the same period. CEO commentary consistently emphasizes disciplined execution and growth in attractive markets, indicating the company is delivering on this priority. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$5.00

$5.03 → $5.00 · observed estimates

FY2027 revenue$21.61B

$21.95B → $21.61B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$5.03	$21,950,508,140	14 / 9
2026-07-25	$5.03	$21,950,508,140	14 / 9
2026-07-26	$5.03	$21,950,508,140	14 / 9
2026-07-27	$5.00	$22,012,351,110	18 / 11
2026-07-28	$5.03	$21,950,508,140	14 / 9
2026-07-29	$5.03	$21,950,508,140	14 / 9
2026-07-30	$4.99	$22,012,351,110	18 / 11
2026-07-31	$5.03	$21,950,517,557	14 / 9
2026-08-01	$5.03	$21,950,517,557	14 / 9
2026-08-02	$4.99	$22,012,351,110	18 / 11
2026-08-03	$4.99	$22,012,351,110	18 / 11
2026-08-04	$4.99	$22,012,351,110	18 / 11
2026-08-05	$5.03	$21,950,517,557	14 / 9
2026-08-06	$5.03	$21,950,517,557	14 / 9
2026-08-08	$4.99	$22,007,603,930	18 / 11
2026-08-09	$5.03	$21,950,517,557	14 / 9
2026-08-10	$4.99	$22,007,603,930	18 / 11
2026-08-12	$4.98	$21,988,479,340	18 / 11
2026-08-13	$5.03	$21,950,517,557	14 / 9
2026-08-14	$5.03	$21,950,517,557	14 / 9
2026-08-15	$5.03	$21,950,517,557	14 / 9
2026-08-16	$5.03	$21,950,517,557	14 / 9
2026-08-17	$5.03	$21,950,517,557	14 / 9
2026-08-18	$5.03	$21,950,517,557	14 / 9
2026-08-19	$5.03	$21,950,517,557	14 / 9
2026-08-20	$5.02	$21,926,642,345	14 / 9
2026-08-21	$5.02	$21,926,642,345	14 / 9
2026-08-22	$5.02	$21,926,642,345	14 / 9
2026-08-23	$5.02	$21,926,642,345	14 / 9
2026-08-24	$5.02	$21,926,642,345	14 / 9
2026-08-25	$5.02	$21,926,642,345	14 / 9
2026-08-26	$5.02	$21,926,642,345	14 / 9
2026-08-27	$5.02	$21,926,642,345	14 / 9
2026-08-28	$5.02	$21,926,642,345	14 / 9
2026-08-29	$5.02	$21,926,642,345	14 / 9
2026-08-30	$5.02	$21,926,642,345	14 / 9
2026-08-31	$5.02	$21,926,642,345	14 / 9
2026-09-01	$5.02	$21,926,460,527	14 / 9
2026-09-02	$5.02	$21,926,460,527	14 / 9
2026-09-03	$5.02	$21,926,460,527	14 / 9
2026-09-04	$5.02	$21,926,460,527	14 / 9
2026-09-05	$5.02	$21,926,460,527	14 / 9
2026-09-06	$5.02	$21,926,460,527	14 / 9
2026-09-07	$5.02	$21,926,460,527	14 / 9
2026-09-08	$5.02	$21,926,460,527	14 / 9
2026-09-09	$5.01	$21,901,899,903	14 / 9
2026-09-10	$5.00	$21,911,259,003	14 / 9
2026-09-11	$5.00	$21,911,259,003	14 / 9
2026-09-12	$5.00	$21,911,259,003	15 / 9
2026-09-13	$5.00	$21,911,259,003	15 / 9
2026-09-14	$5.00	$21,911,259,003	15 / 9
2026-09-15	$5.00	$21,911,259,003	15 / 9
2026-09-16	$5.00	$21,911,259,003	15 / 9
2026-09-17	$5.00	$21,911,259,003	15 / 9
2026-09-18	$5.00	$21,911,259,003	15 / 9
2026-09-19	$5.00	$21,911,259,003	15 / 9
2026-09-20	$5.00	$21,911,259,003	15 / 9
2026-09-21	$5.00	$21,911,259,003	15 / 9
2026-09-22	$5.00	$21,911,259,003	15 / 9
2026-09-23	$5.00	$21,911,259,003	15 / 9
2026-09-24	$5.00	$21,911,259,003	15 / 9
2026-09-25	$5.01	$21,849,306,503	15 / 10
2026-09-26	$5.01	$21,849,306,503	15 / 10
2026-09-27	$5.01	$21,815,661,059	15 / 10
2026-09-28	$5.01	$21,815,661,059	15 / 10
2026-09-29	$5.01	$21,813,911,059	15 / 10
2026-09-30	$5.01	$21,813,911,059	15 / 10
2026-10-01	$5.02	$21,805,639,493	15 / 10
2026-10-02	$5.02	$21,805,639,493	15 / 10
2026-10-03	$5.02	$21,805,639,493	15 / 9
2026-10-04	$5.02	$21,748,073,362	15 / 9
2026-10-05	$5.02	$21,748,073,362	15 / 9
2026-10-06	$5.02	$21,719,082,785	15 / 9
2026-10-07	$5.00	$21,675,789,147	15 / 9
2026-10-08	$5.00	$21,660,518,493	15 / 10
2026-10-09	$5.00	$21,660,518,493	15 / 10
2026-10-10	$5.00	$21,660,518,493	15 / 10
2026-10-11	$5.00	$21,660,518,493	16 / 10
2026-10-12	$5.00	$21,660,518,493	16 / 10
2026-10-13	$5.00	$21,660,518,493	16 / 10
2026-10-14	$5.00	$21,660,518,493	16 / 10
2026-10-15	$5.00	$21,610,250,685	16 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	12	9	2
2026-06-01	12	9	2
2026-07-01	10	13	3
2026-08-01	7	12	3
2026-09-01	7	12	3
2026-10-01	7	12	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 12 Hold · 3 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 16–Oct 15 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Wells FargoOct 8

$52.00New observation · no comparable prior

UBSOct 5

$50.00New observation · no comparable prior

$0$28.60$57.20

0 raises · 0 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Return capital to shareholders via buybacks and dividendsRequired source inputs unavailable
Effective execution of growth initiatives under new CEODirect metric needs a verified mapping
Revenue growth near consensusRevenue growth: -3.04%

Next proof point

Oct 16, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-20.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Truist Financial outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a turnaround story with a focus on improving fundamentals. The current thesis state is cautious, given recent weak financial performance and medium confidence in management execution.

What's priced into Truist Financial

The market seems to have priced in a cheap valuation compared to peers, indicating low expectations for significant growth or improvement. The expectations gap is minimal, suggesting that investors are not anticipating major changes in performance.

What the fundamentals likely do

Fundamentals may improve if management successfully enhances execution of growth initiatives and maintains strong asset quality. However, recent financial performance has been weak, and there is a moderate risk of missing future earnings expectations.

What Truist Financial hinges on

The long-term thesis hinges on management's ability to execute on growth initiatives and return capital to shareholders. Additionally, external factors like interest rate changes and sector performance will significantly impact TFC's trajectory.